Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1323, 2010-01, pp. : 11-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bevacizumab/paclitaxel: Nasal septum perforation: case report
Reactions Weekly, Vol. 1, Iss. 1388, 2012-01 ,pp. :
Access to resources
Recommend
Bevacizumab: Fusariosis (first report) and nasal septum perforation: case report
Reactions Weekly, Vol. 1, Iss. 1167, 2007-01 ,pp. :
Docetaxel: First report of nasal septal perforation: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1118, 2006-01 ,pp. :
Docetaxel/paclitaxel: Cutaneous lupus erythematosus (first report with docetaxel): 4 case reports
Reactions Weekly, Vol. 1, Iss. 1022, 2004-01 ,pp. :
Docetaxel/paclitaxel: Peripheral neuropathy: 3 case reports
Reactions Weekly, Vol. 1, Iss. 1435, 2013-01 ,pp. :